2 completed, 1 terminated. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow PhytoCeutica: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma Capecitabine, PHY906 - Pancreatic Cancer | Phase 1 / Phase 2 | Completed | Yale University | 25 | 2006-12-01 | 2015-03-27 |
| Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma PHY906, capecitabine - Hepatocellular Carcinoma, Liver Cancer | Phase 1 / Phase 2 | Completed | PhytoCeutica | 31 | 2003-10-01 | 2007-03-28 |
| Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer PHY906 - Colorectal Neoplasms, Diarrhea | Phase 1 / Phase 2 | Terminated | PhytoCeutica | 30 | 2002-02-01 | 2005-06-24 |
Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Diarrhea (1) · Liver Neoplasms (1) · Pancreatic Neoplasms (1)
PHY 906 (3) · Capecitabine (2)
United States (3) · Taiwan (1)